Waters Parkerson & Co’s Quest Diagnostics DGX Stock Holding History

Waters Parkerson & Co’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$498K	Hold	2,350	–	–	0.02%	142
2026 Q1	$461K	Hold	2,350	–	–	0.02%	139
2025 Q4	$408K	Hold	2,350	–	–	0.02%	149
2025 Q3	$448K	Hold	2,350	–	–	0.02%	136
2025 Q2	$422K	Hold	2,350	–	–	0.02%	141
2025 Q1	$398K	Hold	2,350	–	–	0.02%	144
2024 Q4	$355K	Hold	2,350	–	–	0.02%	150
2024 Q3	$365K	Sell	2,350 -600	-20%	-$89.6K	0.02%	148
2024 Q2	$404K	Hold	2,950	–	–	0.02%	135
2024 Q1	$393K	Sell	2,950 -100	-3%	-$13K	0.02%	135
2023 Q4	$421K	Hold	3,050	–	–	0.02%	125
2023 Q3	$372K	Sell	3,050 -400	-12%	-$53.3K	0.02%	128
2023 Q2	$485K	Sell	3,450 -165	-5%	-$22.7K	0.03%	122
2023 Q1	$511K	Hold	3,615	–	–	0.03%	117
2022 Q4	$566K	Hold	3,615	–	–	0.03%	112
2022 Q3	$444K	Hold	3,615	–	–	0.03%	120
2022 Q2	$481K	Hold	3,615	–	–	0.03%	118
2022 Q1	$495K	Hold	3,615	–	–	0.03%	125
2021 Q4	$625K	Buy	3,615 +165	+5%	+$25.1K	0.03%	117
2021 Q3	$501K	Hold	3,450	–	–	0.03%	125
2021 Q2	$455K	Hold	3,450	–	–	0.03%	129
2021 Q1	$443K	Hold	3,450	–	–	0.03%	129
2020 Q4	$411K	Hold	3,450	–	–	0.03%	130
2020 Q3	$395K	Hold	3,450	–	–	0.03%	119
2020 Q2	$393K	Hold	3,450	–	–	0.03%	115
2020 Q1	$277K	Hold	3,450	–	–	0.03%	126
2019 Q4	$368K	Hold	3,450	–	–	0.03%	122
2019 Q3	$369K	Sell	3,450 -300	-8%	-$30.8K	0.03%	118
2019 Q2	$382K	Hold	3,750	–	–	0.03%	118
2019 Q1	$337K	Sell	3,750 -125	-3%	-$10.8K	0.03%	122
2018 Q4	$323K	Sell	3,875 -75	-2%	-$7.03K	0.03%	113
2018 Q3	$426K	Hold	3,950	–	–	0.03%	112
2018 Q2	$434K	Buy	3,950 +200	+5%	+$20.8K	0.04%	110
2018 Q1	$376K	Sell	3,750 -950	-20%	-$97.3K	0.03%	117
2017 Q4	$463K	Buy	4,700 +350	+8%	+$33.2K	0.04%	111
2017 Q3	$407K	Sell	4,350 -375	-8%	-$39.8K	0.04%	119
2017 Q2	$525K	Hold	4,725	–	–	0.05%	105
2017 Q1	$464K	Hold	4,725	–	–	0.04%	111
2016 Q4	$434K	Sell	4,725 -200	-4%	-$17.2K	0.04%	114
2016 Q3	$417K	Hold	4,925	–	–	0.04%	116
2016 Q2	$401K	Sell	4,925 -300	-6%	-$22.8K	0.04%	115
2016 Q1	$373K	Sell	5,225 -1,600	-23%	-$107K	0.04%	118
2015 Q4	$486K	Sell	6,825 -300	-4%	-$20.2K	0.06%	104
2015 Q3	$438K	Sell	7,125 -650	-8%	-$45.4K	0.06%	103
2015 Q2	$564K	Sell	7,775 -1,727	-18%	-$128K	0.07%	94
2015 Q1	$730K	Sell	9,502 -23,303	-71%	-$1.67M	0.09%	86
2014 Q4	$2.2M	Sell	32,805 -2,475	-7%	-$156K	0.26%	63
2014 Q3	$2.14M	Sell	35,280 -2,080	-6%	-$128K	0.26%	62
2014 Q2	$2.19M	Sell	37,360 -450	-1%	-$26.4K	0.26%	61
2014 Q1	$2.19M	Sell	37,810 -59,841	-61%	-$3.21M	0.27%	61
2013 Q4	$5.23M	Sell	97,651 -1,263	-1%	-$74.9K	0.64%	46
2013 Q3	$6.11M	Sell	98,914 -4,513	-4%	-$270K	0.82%	43
2013 Q2	$6.27M	Buy	+103,427	New	+$6.16M	0.91%	40

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Waters Parkerson & Co's DGX Position: Q2 2026 in Review

Waters Parkerson & Co held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2,350 shares worth $498K. The position accounts for 0.02% of the portfolio, ranked #142.

Waters Parkerson & Co first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.27M in Q2 2013. 631 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Waters Parkerson & Co held 2,350 shares of Quest Diagnostics worth $498K as of Q2 2026.
Waters Parkerson & Co left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.02% of Waters Parkerson & Co's portfolio in Q2 2026, its #142 holding.
Waters Parkerson & Co first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
Waters Parkerson & Co's Quest Diagnostics position peaked at $6.27M in Q2 2013.
631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.